List of Excipients in API cimetidine hydrochloride oral solution
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing cimetidine hydrochloride oral solution
Detailed excipient profiles for cimetidine hydrochloride oral solution
Excipient focus: FD&C YELLOW NO. 6
cimetidine hydrochloride oral solution drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
cimetidine hydrochloride oral solution drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
cimetidine hydrochloride oral solution drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ORANGE
cimetidine hydrochloride oral solution drug variants containing ORANGE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing ORANGE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
cimetidine hydrochloride oral solution drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
cimetidine hydrochloride oral solution drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
cimetidine hydrochloride oral solution drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
cimetidine hydrochloride oral solution drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
cimetidine hydrochloride oral solution drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
cimetidine hydrochloride oral solution drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
cimetidine hydrochloride oral solution drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
cimetidine hydrochloride oral solution drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
| >Company | >Ingredient | >NDC |
cimetidine hydrochloride oral solution drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch